In vivo evolution of bacterial resistance in two cases of Enterobacter aerogenes infections during treatment with imipenem

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Philippe, Nadège ^a,b   Maigre, Laure ^a   Santini, Sébastien ^b   Pinet, Elizabeth ^a,c   Claverie, Jean Michel ^b   Davin Régli, Anne Véronique ^a   Pagès, Jean Marie ^a   Masi, Muriel ^a  

^a Aix Marseille University   (France)

^b CNRS Aix Marseille University   (France)

^c Mérieux NutriSciences Laboratoire de Microbiologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; ERTAPENEM; ERYTHROMYCIN; FLEROXACIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; POLYMYXIN B; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; CASE REPORT; CONTROLLED STUDY; CPXA GENE; DRUG ACCUMULATION; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IN VIVO STUDY; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OMP35 GENE; OMP36 GENE; PHOQ GENE; PMRB GENE; ROB GENE; CELL MEMBRANE PERMEABILITY; DNA SEQUENCE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; GENETICS; MICROBIOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; HUMANS; IMIPENEM; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 84946944618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138828     Document Type: Article

References (58)

1. CDC. Antibiotic Resistance Threats in the United States, 2013. Available: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.
2. Arpin C, Coze C, Rogues AM, Gachie JP, Bebear C, Quentin C. 1996. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Micro-biol. 34: 2163-2169. PMID: 8862578
3. Davin-Regli A, Monnet D, Saux P, Bosi C, Charrel R, Barthelemy A, et al. 1996. Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J Clin Microbiol. 34: 1474-1480. PMID: 8735101
4. Bosi C, Davin-Regli A, Bornet C, Mallea M, Pages JM, Bollet C. 1999. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol. 37: 2165-2169. PMID: 10364580
5. de Champs C, Henquell C, Guelon D, Sirot D, Gazuy N, Sirot J. 1993. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem. J Clin Microbiol. 31: 123-127. PMID: 8417016
6. Charrel RN, Pagès JM, De Micco P, Mallea M. 1996. Prevalence of outer membrane porin alteration in β-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob Agents Chemother. 40: 2854-2858. PMID: 9124854
7. Bornet C, Davin-Regli A, Bosi C, Pages JM, Bollet C. 2000. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol. 38: 1048-1052. PMID: 10698994
8. Thiolas A, Bollet C, La Scola B, Raoult D, Pagès JM. 2005. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother. 49: 1354-1358. PMID: 15793111
9. Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Bourg G, Davin-Regli A, et al. 2012. Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates. Clin Microbiol Infect. 18: 539-545. doi: 10.1111/j.1469-0691.2011.03607.x PMID: 21883663
10. Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Pagès JM, Davin-Regli A. 2013. An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates. Int J Antimicrob Agents. 41: 130-136. doi: 10.1016/j.ijantimicag.2012.10.010 PMID: 23280442
11. Lavigne JP, Bouziges N, Chanal C, Mahamat A, Michaux-Charachon S, Sotto A. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital. J Clin Microbiol. 2004; 42:3805-8. PMID: 15297534
12. Tran QT, Dupont M, Lavigne JP, Chevalier J, Pagès JM, Sotto A, et al. Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2009; 53:1652-6. doi: 10.1128/AAC.00822-08 PMID: 19164140
13. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol. 2011; 19:588-95. doi: 10.1016/j.tim.2011.09.005 PMID: 22078325
14. Robert J, Pantel A, Mérens A, Lavigne JP, Nicolas-Chanoine MH; ONERBA's Carbapenem Resistance Study Group. 2014. Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12. J Antimicrob Chemother. 69: 2706-2712. doi: 10.1093/jac/dku208 PMID: 24942333
15. Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, et al. 2008. Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr Drug Targets. 9: 750-759. PMID: 18781921
16. Pagès JM, James CE, Winterhalter M. 2008. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol. 6:893-903. doi: 10.1038/nrmicro1994 PMID: 18997824
17. Nikaido H, Pagès JM. 2012. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. 36: 340-363. doi: 10.1111/j.1574-6976.2011.00290.x PMID: 21707670
18. Mallea M, Chevalier J, Bornet C, Eyraud A, Davin-Regli A, Bollet C, et al. 1998. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology. 144: 3003-3009. PMID: 9846735
19. Dé E, Baslé A, Jaquinod M, Saint N, Malléa M, Molle G, Pagès JM. 2001. A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol Microbiol. 41: 189-198. PMID: 11454211
20. Thiolas A, Bornet C, Davin-Régli A, Pagès JM, Bollet C. 2004. Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem Biophys Res Commun. 317: 851-856. PMID: 15081418
21. Bornet C, Chollet R, Malléa M, Chevalier J, Davin-Regli A, Pagès JM, et al. 2003. Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun. 301: 985-990. PMID: 12589810
22. Chevalier J, Mulfinger C, Garnotel E, Nicolas P, Davin-Régli A, Pagès JM. 2008. Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. PLoS One. 3: e3203. doi: 10.1371/journal.pone.0003203 PMID: 18787654
23. Doumith M, Ellington MJ, Livermore DM, Woodford N. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother. 63: 659-667. doi: 10.1093/jac/dkp029 PMID: 19233898
24. Schneiders T, Amyes SG, Levy SB. 2003. Role of acrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother. 47: 2831-2837. PMID: 12936981
25. Koutsolioutsou A, Peña-Llopis S, Demple B. 2005. Constitutive soxR mutations contribute to multipleantibiotic resistance in clinical Escherichia coli isolates. Antimicrob Agents Chemother. 49: 2746-2752. PMID: 15980345
26. Abouzeed YM, Baucheron S, Cloeckaert A. 2008. ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother. 52: 2428-2434. doi: 10.1128/AAC.00084-08 PMID: 18443112
27. Zheng J, Cui S, Meng J. 2009. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother. 63: 95-102. doi: 10.1093/jac/dkn448 PMID: 18984645
28. Blair JM, Bavro VN, Ricci V, Modi N, Cacciotto P, Kleinekathöfer U, et al. 2015. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc Natl Acad Sci U S A. 112:3511-3516. doi: 10.1073/pnas.1419939112 PMID: 25737552
29. Shin SH, Kim S, Kim JY, Lee S, Um Y, Oh MK, et al. 2012. Complete genome sequence of Enterobacter aerogenes KCTC 2190. J Bacteriol. 194: 2373-2374. doi: 10.1128/JB.00028-12 PMID: 22493190
30. Bohnert JA, Schuster S, Szymaniak-Vits M, Kern WV. 2011. Determination of real-time efflux phenotypes in Escherichia coli AcrB binding pocket phenylalanine mutants using a 1,2'-dinaphthylamine efflux assay. PLoS One. 6: e21196. doi: 10.1371/journal.pone.0021196 PMID: 21698261
31. Salzberg SL, Delcher AL, Kasif S, White O. 1998. Microbial gene identification using interpolated Markov models. Nucleic Acids Res. 26: 544-548. PMID: 9421513
32. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 9:75. doi: 10.1186/1471-2164-9-75 PMID: 18261238
33. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, et al. 2014. The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res. 42: D206-214. doi: 10.1093/nar/gkt1226 PMID: 24293654
34. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25: 1754-1760. doi: 10.1093/bioinformatics/btp324 PMID: 19451168
35. Milne I, Stephen G, Bayer M, Cock PJ, Pritchard L, Cardle L, et al. 2013. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform. 14: 193-202. doi: 10.1093/bib/bbs012 PMID: 22445902
36. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18: 821-829. doi: 10.1101/gr.074492.107 PMID: 18349386
37. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One. 5: e11147. doi: 10.1371/journal.pone.0011147 PMID: 20593022
38. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol. 215: 403-410. PMID: 2231712
39. Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. 2011. PHAST: a fast phage search tool. Nucleic Acids Res. 39: W347-352. doi: 10.1093/nar/gkr485 PMID: 21672955
40. Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 34: D32-36. PMID: 16381877
41. Chapman JS, Georgopapadakou NH. 1989. Fluorometric assay for fleroxacin uptake by bacterial cells. Antimicrob Agents Chemother. 33: 27-29. PMID: 2540707
42. Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, et al. 2014. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A. 111: 4988-4993. doi: 10.1073/pnas.1321364111 PMID: 24639510
43. Villa L, Carattoli A, Nordmann P, Carta C, Poirel L. 2013. Complete sequence of the IncT-type plasmid pT-OXA-181 carrying the blaOXA-181 carbapenemase gene from Citrobacter freundii. Antimicrob Agents Chemother. 57: 1965-1967. doi: 10.1128/AAC.01297-12 PMID: 23357767
44. Diene SM, Merhej V, Henry M, El Filali A, Roux V, Robert C, et al. 2013. The rhizome of the multidrugresistant Enterobacter aerogenes genome reveals how new "killer bugs" are created because of a sympatric lifestyle. Mol Biol Evol. 30: 369-383. doi: 10.1093/molbev/mss236 PMID: 23071100
45. Lee EH, Collatz E, Podglajen I, Gutmann L. 1996. A rob-like gene of Enterobacter cloacae affecting porin synthesis and susceptibility to multiple antibiotics. Antimicrob Agents Chemother. 40: 2029-2033 PMID: 8878575
46. Pérez A, Poza M, Aranda J, Latasa C, Medrano FJ, Tomás M, et al. 2012. Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae. Antimicrob Agents Chemother. 56: 6256-6266. doi: 10.1128/AAC.01085-12 PMID: 23006750
47. Raivio TL. 2014. Everything old is new again: an update on current research on the Cpx envelope stress response. Biochim Biophys Acta. 1843: 1529-1541. doi: 10.1016/j.bbamcr.2013.10.018 PMID: 24184210
48. Batchelor E, Walthers D, Kenney LJ, Goulian M. 2005. The Escherichia coli CpxA-CpxR envelope stress response system regulates expression of the porins ompF and ompC. J Bacteriol. 187: 5723-5731. PMID: 16077119
49. Groisman EA. 2001. The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol. 183: 1835-1842. PMID: 11222580
50. Chen HD, Groisman EA. 2013. The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications. Annu Rev Microbiol. 67: 83-112. doi: 10.1146/annurevmicro-092412-155751 PMID: 23799815
51. Tsai YK, Liou CH, Fung CP, Lin JC, Siu LK. 2013. Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems. PLoS One. 8: e79640. doi: 10.1371/journal.pone.0079640 PMID: 24265784
52. Mahoney TF, Silhavy TJ. 2013. The Cpx stress response confers resistance to some, but not all, bactericidal antibiotics. J Bacteriol. 195: 1869-1874. doi: 10.1128/JB.02197-12 PMID: 23335416
53. Barrow K, Kwon DH. 2009. Alterations in two-component regulatory systems of PhoPQ and PmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 53: 5150-514. doi: 10.1128/AAC.00893-09 PMID: 19752280
54. Sun S, Negrea A, Rhen M, Andersson DI. 2009. Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother. 53: 2298-2305. doi: 10.1128/AAC. 01016-08 PMID: 19332669
55. Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, et al. 2011. phoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistintreated cystic fibrosis patients. Antimicrob Agents Chemother. 55: 5761-5769. doi: 10.1128/AAC. 05391-11 PMID: 21968359
56. Moskowitz SM, Brannon MK, Dasgupta N, Pier M, Sgambati N, Miller AK, et al. 2012. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother. 56: 1019-1030. doi: 10.1128/AAC.05829-11 PMID: 22106224
57. Jayol A, Poirel L, Brink A, Villegas MV, Yilmaz M, Nordmann P. 2014. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother. 58: 4762-4766. doi: 10.1128/AAC.00084-14 PMID: 24914122
58. Shprung T, Peleg A, Rosenfeld Y, Trieu-Cuot P, Shai Y. 2012. Effect of PhoP-PhoQ activation by broad repertoire of antimicrobial peptides on bacterial resistance. J Biol Chem. 287: 4544-4551. doi: 10. 1074/jbc.M111.278523 PMID: 22158870